Limerik (Piperacillin, Tazobactam)

Limerik (piperacillin/tazobactam) is used to treat infections caused by susceptible bacteria across several organ systems.

• Complicated intra‑abdominal infections: provides broad coverage including anaerobes and Pseudomonas.
• Complicated urinary tract infections: eradicates Gram‑negative pathogens and resistant strains.
• Hospital‑acquired pneumonia, including ventilator‑associated pneumonia: achieves bacterial clearance in severe lung infections.
• Skin and soft‑tissue infections: treats mixed flora including MRSA‑susceptible strains.
• Febrile neutropenia: offers empiric therapy against high‑risk bacterial pathogens.

• Piperacillin binds to penicillin‑binding proteins, inhibiting the final step of bacterial cell‑wall peptidoglycan synthesis. Tazobactam is a β‑lactamase inhibitor that forms a stable complex with class A β‑lactamases, protecting piperacillin from enzymatic degradation. The combination thereby expands the antimicrobial spectrum to include many β‑lactamase‑producing Gram‑negative organisms, enabling effective bacterial killing.

Adverse reactions to Limerik may vary from mild to severe and should be monitored during therapy.

Common Side Effects

• Diarrhea: loose stools occurring during treatment.
• Nausea: feeling of stomach upset.
• Injection site pain: local discomfort at the intramuscular site.
• Rash: mild skin erythema.
• Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Stevens‑Johnson syndrome: rare mucocutaneous disorder.
• Clostridioides difficile‑associated diarrhea: severe colitis risk.
• Seizures: especially in patients with renal impairment.
• Severe neutropenia: marked reduction in white blood cells.
• Acute renal impairment: sudden decline in kidney function.

Before prescribing Limerik, clinicians should consider several precautionary measures to ensure safe use.

• Renal function: adjust dose in patients with impaired clearance.
• Allergy history: avoid in individuals with known hypersensitivity to penicillins or β‑lactamase inhibitors.
• Pregnancy and lactation: use only if benefit outweighs risk, as safety data are limited.
• Concurrent antibiotics: evaluate for overlapping toxicity.
• Monitoring: observe for signs of hematologic abnormalities such as neutropenia.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Limerik can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Probenecid: reduces renal excretion of piperacillin, increasing toxicity.
• Live bacterial vaccines: risk of infection due to antimicrobial activity.
• Concurrent use of other β‑lactam antibiotics: may increase risk of hypersensitivity.

Moderate Interactions (Monitor Closely)

• Warfarin: possible alteration of INR, monitor coagulation.
• Loop diuretics: may increase risk of nephrotoxicity.
• Aminoglycosides: monitor renal function due to additive nephrotoxic potential.